Search Results 111-120 of 18685 for hepatitis
Hepatitis C, one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage, ...
The purpose of this study is to assess dose-related safety, early efficacy, pharmacokinetics and pharmacodynamics of INT-787 in patients with severe alcohol- ...
This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study ( ...
Hepatitis B is a disease that affects the liver. Human papillomavirus (HPV). The CDC recommends the HPV vaccine for children at ages 11 or 12. But if you didn't ...
... hepatitis (SAH). Aim: To perform a phase 2a "proof of concept" placebo-controlled, dose-ranging study of Imm 124-E (hyperimmune bovine colostrum enriched ...
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
Living with alcoholic hepatitis? Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, ...
Acute hepatitis; Acute liver failure · Alcoholic hepatitis; Alpha-1-antitrypsin deficiency; Amyloidosis · Autoimmune hepatitis; Biliary atresia; Budd-Chiari ...
A Study for the Use of Hepatitis C Virus Seropositive Donors into Hepatitis C Seronegative Liver Transplant Recipients. Print details. Share; Facebook · Twitter.
The purpose of this study is to evaluate the safety and effectiveness of zetomipzomib in addition to standard-of-care in patients with autoimmune hepatitis (AIH) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.